AnGes, Inc. (TYO:4563)
Japan · Delayed Price · Currency is JPY 49.00
0.00 (0.00%)
Aug 6, 2026, 11:30 AM JST
AnGes Market Cap
AnGes has a market cap or net worth of 19.54 billion as of August 5, 2026. Its market cap has decreased by -17.47% in one year.
Market Cap
19.54B
Enterprise Value
19.40B
Revenue
908.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
49.00
ChartMarket Cap Chart
Since September 25, 2002, AnGes's market cap has decreased from 23.36B to 19.54B, a decrease of -16.34%. That is a compound annual growth rate of -0.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 19.54B | -17.33% |
| Dec 30, 2025 | 23.64B | 57.68% |
| Dec 30, 2024 | 14.99B | 5.37% |
| Dec 29, 2023 | 14.23B | -31.96% |
| Dec 30, 2022 | 20.91B | -64.42% |
| Dec 30, 2021 | 58.78B | -64.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Heartseed | 39.53B |
| Cuorips | 39.10B |
| Healios K.K. | 34.16B |
| Japan Tissue Engineering | 31.76B |
| Renascience | 20.83B |
| StemRIM | 18.93B |
| CanBas | 14.12B |
| RaQualia Pharma | 12.70B |